PlainRecalls
FDA Drug Low Class III Terminated

Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01

Reported: September 19, 2018 Initiated: August 7, 2018 #D-1186-2018

Product Description

Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

Details

Units Affected
11,799 bottles of 100
Distribution
Distributed Nationwide in the US
Location
Morgantown, WV

Frequently Asked Questions

What product was recalled?
Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01. Recalled by Mylan Pharmaceuticals Inc.. Units affected: 11,799 bottles of 100.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 19, 2018. Severity: Low. Recall number: D-1186-2018.